Secrist John Paul 4
4 · Cyteir Therapeutics, Inc. · Filed Feb 24, 2022
Insider Transaction Report
Form 4
Secrist John Paul
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-22+42,000→ 42,000 totalExercise: $5.96Exp: 2032-02-22→ Common Stock (42,000 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying this stock option award vest as to 2.083% in 48 equal monthly installments, subject to the Reporting Person's continued employment with the Company through the applicable vesting date.